Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02044211 · ClinicalTrials.gov registry record · Phase 2
Blended Collaborative Care for Heart Failure and Co-Morbid Depression
A Phase 2 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 2
- Development phase
- 756
- Enrollment target
NCT02044211: Completed Phase 2 study, sponsored by University of Pittsburgh.
NCT02044211 is a Phase 2 study that has completed, run by University of Pittsburgh. The registered enrollment target is 756 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (468% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02044211, a Phase 2 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 756 participants
- Enrollment target
Study Summary
Depression is highly prevalent among patients with heart failure (HF) and associated with lower levels of health-related quality of life and physical functioning, and higher risk of rehospitalization and mortality, and higher health costs. This Project will compare the effectiveness of a "blended" telephone-delivered collaborative care intervention for treating both HF and depression to: (1) collaborative care for HF-alone ("enhanced usual care"; eUC); and (2) doctors' "usual care" for depression (UC). If proven effective and cost-effective, the potentially more powerful, scalable, efficient "blended" care approach for treating HF and co-morbid depression could have profound implications for improving chronic illness care and stimulate development of "blended" interventions for treating other clusters of related medical conditions.
Primary Outcome
Mental Health-Related Quality of Life
Interventions
- BEHAVIORAL Collaborative Care for Heart Failure
- BEHAVIORAL Collaborative Care for Depression
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 756 participants |
| Start Date | 2014-02 |
| Est. Completion | 2020-07 |
| Phase | Phase 2 |
What the finished NCT02044211 record still lists
NCT02044211 is an interventional study that assigns participants to a tested intervention. The registered 756 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (468% higher).
The record links to 0 conditions, and to 2 interventions - of which Collaborative Care for Heart Failure is the first listed.
NCT02044211 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02044211 about?
NCT02044211 is a clinical study titled "Blended Collaborative Care for Heart Failure and Co-Morbid Depression". Depression is highly prevalent among patients with heart failure (HF) and associated with lower levels of health-related quality of life and physical functioning, and higher risk of rehospitalization and mortality, and higher health costs. This Project will compare the effectiveness of a "blended" t...
What is the current status of trial NCT02044211?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 756 participants. The study started on 2014-02. Estimated completion is 2020-07.
What interventions are being tested in trial NCT02044211?
The interventions under investigation include: Collaborative Care for Heart Failure (BEHAVIORAL), Collaborative Care for Depression (BEHAVIORAL).
Who is sponsoring clinical trial NCT02044211?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02044211's enrollment target sits among peer trials
756 43rd of 2000 higher than 1,958 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05869149 · 756 participants · NA
Systems Science Approaches to Improve Access to Healthier Foods: The FRESH Trial
- NCT06095583 · 756 participants · Phase 3
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
- NCT05379985 · 754 participants · Phase 1
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
- NCT05427370 · 754 participants · NA
The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia